查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
诊断产品契约製造的全球市场：按设备（体外诊断/影像诊断）、服务（设备开发和製造、品管、包装和组装）、应用和地区 - 预测（截至 2028 年）
市场调查报告书
商品编码
1462409

诊断产品契约製造的全球市场：按设备（体外诊断/影像诊断）、服务（设备开发和製造、品管、包装和组装）、应用和地区 - 预测（截至 2028 年）

Diagnostic Contract Manufacturing Market by Device (In Vitro Diagnostic Devices and Diagnostic Imaging Devices), Service (Device Development & Manufacturing, Quality Management, and Packaging & Assembly), Application, Region - Global Forecast to 2028
出版日期: | 出版商: MarketsandMarkets | 英文 220 Pages | 订单完成后即时交付

价格
简介目录

全球诊断产品契约製造市场规模预计将从 2023 年的 260 亿美元成长到 2028 年的 449 亿美元，预测期内复合年增长率为 11.5%。

市场的成长主要是由製造过程中机器人和自动化的日益采用所推动的。另一方面，再製造诊断影像系统的日益采用是诊断产品契约製造市场成长的问题。

调查范围
调查年份 2022-2028
基准年 2023年
预测期 2023-2028
单元 金额（美元）
部分 设备/服务/应用程式
目标区域 北美、欧洲、亚太等地区

按设备划分，诊断影像设备领域预计在预测期内呈现最高成长率：

影像设备包括CT、X光、MRI、超音波等影像设备。由于经济快速成长，预计未来几年开发中国家对这些设备的采用将会增加。

从应用来看，整形外科预计在预测期内将显示最高的复合年增长率：

从应用来看，循环系统医学领域将在2022年引领市场，其中整形外科成长最高。支持整形外科应用成长的因素是人口老化的加剧以及整形外科疾病和病症的盛行率不断增加。

按地区划分，亚太地区预计成长率最高：

由于低廉的人事费用和快速变化的医疗基础设施，亚太地区提供了巨大的市场潜力。

本报告调查了全球诊断产品契约製造市场，并提供了市场概况、市场影响因素和市场机会分析、技术趋势、法律制度、市场规模趋势和预测，以及各个细分市场和地区的详细分析。景观、主要企业简介等

目录

第一章 简介

第二章调查方法

第三章执行摘要

第 4 章重要考察

第五章市场概况

  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
    • 任务
  • 供应链分析
  • 波特五力分析
  • 生态系分析
  • 监管分析
  • 主要会议及活动
  • 技术分析

第六章诊断产品契约製造市场：依设备分类

  • 体外诊断设备
    • 消耗品
    • 装置
  • 诊断影像设备
    • CT
    • 超音波
    • X射线
    • MRI
    • 其他的
  • 其他的

第七章诊断产品契约製造市场：依服务分类

  • 装置开发及製造服务
  • 品管服务
  • 包装/组装服务
  • 其他的

第八章诊断产品契约製造市场：依应用分类

  • 体外诊断设备的应用
    • 感染疾病
    • 糖尿病
    • 瘤
    • 心臟病
    • 其他的
  • 诊断影像设备的应用
    • 循环系统
    • 肿瘤学
    • 整形外科
    • 神经科
    • 其他的
  • 其他设备用途
    • 胃肠病学
    • 妇科
    • 其他的

第九章诊断产品契约製造市场：按地区

  • 亚太地区
  • 北美洲
  • 欧洲
  • 其他地区

第10章竞争格局

  • 概述
  • 主要企业/主要企业策略
  • 收益分析
  • 市场占有率分析
  • 企业评价矩阵
  • 企业足迹分析
  • 竞争基准化分析
  • 竞争场景

第十一章 公司简介

  • 主要企业
    • JABIL INC.
    • FLEX LTD.
    • PLEXUS CORP.
    • SANMINA CORPORATION
    • TE CONNECTIVITY LTD.
    • CELESTICA INC.
    • INTEGER HOLDINGS CORPORATION
    • NIPRO CORPORATION
    • THERMO FISHER SCIENTIFIC
    • WEST PHARMACEUTICAL SERVICES, INC.
    • BENCHMARK ELECTRONICS INC.
    • KIMBALL ELECTRONICS INC.
    • KMC SYSTEMS
    • SAVYON DIAGNOSTICS
    • NOVA BIOMEDICAL
  • 其他公司
    • CENOGENICS CORPORATION
    • CONE BIOPRODUCTS
    • AVIOQ, INC.
    • PHILLIPS-MEDISIZE CORPORATION
    • INVETECH
    • MERIDIAN BIOSCIENCE, INC.
    • NOLATO AB
    • FUJIREBIO
    • SEKISUI
    • PRESTIGE DIAGNOSTICS
    • BIOKIT

第十二章附录

简介目录
Product Code: MD 8985

The global diagnostic contract manufacturing market is projected to reach USD 44.9 Billion by 2028 from USD 26.0 Billion in 2023, at a CAGR of 11.5% during the forecast period. The growth of this market is majorly driven by the growth in the adoption of robotics and automation in manufacturing processes. However, the increasing adoption of refurbished diagnostic imaging systems challenges the growth of the diagnostic contract manufacturing market.

Scope of the Report
Years Considered for the Study2022-2028
Base Year2023
Forecast Period2023-2028
Units ConsideredValue (USD) Billion
SegmentsDevice, Service, and Application
Regions coveredNorth America, Europe, Asia Pacific, and Rest of the World

"The diagnostic imaging devices segment accounted for the highest growth rate in the diagnostic contract manufacturing market, by device, during the forecast period."

Based on the type segment, the diagnostic contract manufacturing market is segmented into In vitro diagnostic devices, diagnostic imaging devices, and other devices. Diagnostic imaging devices include CT, X-ray, MRI, Ultrasound, and other imaging devices. Due to rapid economic growth, the adoption of these devices is expected to increase in developing countries in the coming years.

"Orthopedics application segment accounted for the highest CAGR during the forecast period among diagnostic imaging devices application."

Based on application, the diagnostic imaging devices market is segmented into cardiology, neurology, orthopedics, oncology, and others. In 2022, cardiology dominated the market, and orthopedics observed the highest growth rate. Factors supporting the growth of orthopedics applications are the rising geriatric population and the growing prevalence of orthopedic diseases and disorders.

"The Asia Pacific segment accounted for the highest growth rate in the diagnostic contract manufacturing systems market, by region, during the forecast period."

Based on the region, the global diagnostic contract manufacturing market is categorized into North America, Europe, Asia Pacific, and Rest of the World. Asia Pacific is expected to witness a high growth rate during the forecast period. Low labor costs and rapidly changing healthcare infrastructure hold massive potential for the Asia Pacific diagnostic contract manufacturing market.

Breakdown of supply-side primary interviews by company type, designation, and region:

  • By Company Type: Tier 1- 55%, Tier 2- 40%, and Tier 3- 5%
  • By Designation: C-level - 37%, Director-level - 48%, and Others-15%
  • By Region: North America- 56%, Europe -17%, Asia- Pacific -20%, and Rest of the World -7%

Prominent companies include Jabil Inc. (US), Flex Ltd. (Singapore), Plexus Corp. (US), Sanmina Corporation (US), TE Connectivity Ltd. (Switzerland), Celestica Inc. (Canada), Integer Holdings Corporation (US), Nipro Corporation (Japan), Thermo Fisher Scientific (US), West Pharmaceutical Services Inc. (US), Benchmark Electronics Inc. (US), Kimball Electronics Inc. (US), KMS Systems (US), Savyon Diagnostics (Israel), Nova Biomedical (US), Cenogenics Corporation (US), Cone Bioproducts (US), Avioq, Inc. (US), Philips-Medisize Corporation (US), Invetech (Australia), Meridian Bioscience, Inc. (US), Nolato AB (Sweden), Fujirebio (Japan), Sekisui (US), Prestige Diagnostics (UK), and Biokit (Spain).

Research Coverage

This research report categorizes the diagnostic contract manufacturing market by device (In Vitro Diagnostic Devices, Diagnostic Imaging Devices, Other Devices), services (Device Development and Manufacturing Services, Quality Management Services, Packaging and Assembly Services, and Other Services), end-user (In Vitro Diagnostic Devices (Infectious Diseases, Oncology, Cardiology, Others), Diagnostic Imaging Devices (Cardiology, Oncology, Orthopedics, Neurology, Others), Other Devices (Gastroenterology, Gynecology, Others), and region (North America, Europe, Asia Pacific, and Rest of the World). The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the diagnostic contract manufacturing market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. New product & service launches, mergers and acquisitions, and recent developments associated with the diagnostic contract manufacturing market. Competitive analysis of upcoming startups in the diagnostic contract manufacturing market ecosystem is covered in this report.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall diagnostic contract manufacturing market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers (early diagnosis and widening scope of clinical applications, adoption of robotics and automation in manufacturing processes, growing outsourcing activity by IVD manufacturers, and high cost of in-house IVD manufacturing), restraints (IP protection concerns and possibility of theft), opportunities (growth opportunities in emerging economies), and challenges (Increasing adoption of refurbished diagnostic imaging systems, lack of constant innovation to balance technological capabilities against costs, and shortage of skilled labor).
  • Market Development: Comprehensive information about lucrative markets - the report analyses the diagnostic contract manufacturing market across varied regions.
  • Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the diagnostic contract manufacturing market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Jabil Inc. (US), Flex Ltd. (Singapore), Plexus Corp. (US), Sanmina Corporation (US), TE Connectivity Ltd. (Switzerland), Celestica Inc. (Canada), among others in the diagnostic contract manufacturing market strategies.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • TABLE 1 INCLUSIONS AND EXCLUSIONS
  • 1.3 STUDY SCOPE
    • FIGURE 1 DIAGNOSTIC CONTRACT MANUFACTURING MARKET SEGMENTATION
    • 1.3.1 YEARS CONSIDERED
  • 1.4 CURRENCY CONSIDERED
  • 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: RESEARCH DESIGN METHODOLOGY
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 3 PRIMARY SOURCES
    • 2.1.3 KEY INDUSTRY INSIGHTS
      • 2.1.3.1 Key data from primary sources
      • 2.1.3.2 Breakdown of primary interviews
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
      • 2.2.1.1 Approach 1: Company revenue estimation approach
    • FIGURE 5 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH
      • 2.2.1.2 Approach 2: Presentations of companies and primary interviews
      • 2.2.1.3 Approach 3: COGS approach
    • FIGURE 6 DEMAND-SIDE ESTIMATION FOR DIAGNOSTIC CONTRACT MANUFACTURING MARKET
      • 2.2.1.4 Approach 4: Parent market approach (in-house vs. outsourcing market)
      • 2.2.1.5 Growth forecast
      • 2.2.1.6 CAGR projections
    • FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • 2.2.2 TOP-DOWN APPROACH
    • FIGURE 8 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: TOP-DOWN APPROACH
  • 2.3 DATA TRIANGULATION
    • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • 2.4 STUDY ASSUMPTIONS
  • 2.5 RESEARCH LIMITATIONS AND RISK ASSESSMENT
    • TABLE 2 RISK ASSESSMENT: DIAGNOSTIC CONTRACT MANUFACTURING MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 10 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 11 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2023 VS. 2028 (USD MILLION)
    • FIGURE 12 IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
    • FIGURE 13 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2023 VS. 2028 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 DIAGNOSTIC CONTRACT MANUFACTURING MARKET OVERVIEW
    • FIGURE 14 HIGH COST OF IN-HOUSE MANUFACTURING TO DRIVE DEMAND FOR DIAGNOSTIC CONTRACT MANUFACTURING
  • 4.2 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION (2023-2028)
    • FIGURE 15 ASIA PACIFIC MARKET TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • 4.3 ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE AND COUNTRY (2022)
    • FIGURE 16 IVD DEVICES SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC DIAGNOSTIC CONTRACT MANUFACTURING MARKET IN 2022
  • 4.4 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 17 MARKET IN CHINA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 18 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing demand for early diagnosis and widening scope of clinical applications
      • 5.2.1.2 Adoption of robotics and automation in manufacturing processes
      • 5.2.1.3 Growing outsourcing activity by IVD manufacturers
      • 5.2.1.4 High cost of in-house IVD manufacturing
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 IP protection concerns and possibility of IP theft
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growth opportunities in emerging economies
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Increasing adoption of refurbished diagnostic imaging systems
      • 5.2.4.2 Lack of constant innovation to balance technological capabilities against costs
      • 5.2.4.3 Shortage of skilled labor
  • 5.3 SUPPLY CHAIN ANALYSIS
    • FIGURE 19 DIAGNOSTIC CONTRACT MANUFACTURING: SUPPLY CHAIN
  • 5.4 PORTER'S FIVE FORCES ANALYSIS
    • 5.4.1 THREAT OF NEW ENTRANTS
    • 5.4.2 THREAT OF SUBSTITUTES
    • 5.4.3 BARGAINING POWER OF SUPPLIERS
    • 5.4.4 BARGAINING POWER OF BUYERS
    • 5.4.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.5 ECOSYSTEM ANALYSIS
    • FIGURE 20 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: ECOSYSTEM ANALYSIS
    • 5.5.1 ROLE IN ECOSYSTEM
    • FIGURE 21 KEY PLAYERS IN DIAGNOSTIC CONTRACT MANUFACTURING MARKET ECOSYSTEM
  • 5.6 REGULATORY ANALYSIS
    • TABLE 3 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING DIAGNOSTIC CONTRACT MANUFACTURING
    • 5.6.1 NORTH AMERICA
      • 5.6.1.1 US
    • TABLE 4 US: CLASSIFICATION OF MEDICAL EQUIPMENT
      • 5.6.1.2 Canada
    • 5.6.2 EUROPE
    • 5.6.3 ASIA PACIFIC
      • 5.6.3.1 Japan
    • TABLE 5 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
    • TABLE 6 JAPAN: CLASSIFICATION OF IVD REAGENTS
      • 5.6.3.2 China
    • TABLE 7 CHINA: CLASSIFICATION OF MEDICAL DEVICES
      • 5.6.3.3 India
  • 5.7 KEY CONFERENCES AND EVENTS IN 2022-2023
    • TABLE 8 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2022-2023
  • 5.8 TECHNOLOGY ANALYSIS

6 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE

  • 6.1 INTRODUCTION
    • TABLE 9 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION)
  • 6.2 IN VITRO DIAGNOSTIC DEVICES
    • TABLE 10 IN VITRO DIAGNOSTIC DEVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 11 IN VITRO DIAGNOSTIC DEVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.1 IVD CONSUMABLES
      • 6.2.1.1 Consumables segment to dominate IVD contract manufacturing market
    • TABLE 12 IVD CONSUMABLES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.2.2 IVD EQUIPMENT
      • 6.2.2.1 Automation, advancements, and emphasis on efficient diagnostics to drive growth
    • TABLE 13 IVD EQUIPMENT: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.3 DIAGNOSTIC IMAGING DEVICES
    • TABLE 14 DIAGNOSTIC IMAGING DEVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 15 DIAGNOSTIC IMAGING DEVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.3.1 CT
      • 6.3.1.1 Rising adoption of CT scanners for detection of tumors to support growth
    • TABLE 16 CT: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.3.2 ULTRASOUND
      • 6.3.2.1 Minimally invasive nature of ultrasound to boost demand
    • TABLE 17 ULTRASOUND: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.3.3 X-RAY
      • 6.3.3.1 Low cost of X-ray imaging compared to other modalities to drive growth
    • TABLE 18 X-RAY: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.3.4 MRI
      • 6.3.4.1 Innovation and advancement in MRI applications to drive demand
    • TABLE 19 MRI: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 6.3.5 OTHER DIAGNOSTIC IMAGING DEVICES
    • TABLE 20 OTHER DIAGNOSTIC IMAGING DEVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 6.4 OTHER DEVICES
    • TABLE 21 OTHER DEVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION)

7 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE

  • 7.1 INTRODUCTION
    • TABLE 22 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION)
  • 7.2 DEVICE DEVELOPMENT AND MANUFACTURING SERVICES
    • 7.2.1 DEVICE MANUFACTURING SERVICES TO WITNESS HIGH GROWTH DURING FORECAST PERIOD
    • TABLE 23 DEVICE DEVELOPMENT AND MANUFACTURING SERVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.3 QUALITY MANAGEMENT SERVICES
    • 7.3.1 STRINGENT REGULATIONS AND INCREASING PRODUCT SAFETY CONCERNS TO DRIVE DEMAND FOR QUALITY MANAGEMENT SERVICES
    • TABLE 24 QUALITY MANAGEMENT SERVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.4 PACKAGING AND ASSEMBLY SERVICES
    • 7.4.1 INCREASING PRODUCT SAFETY CONCERNS FOR MEDICAL DEVICES TO SUPPORT GROWTH
    • TABLE 25 PACKAGING AND ASSEMBLY SERVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 7.5 OTHER SERVICES
    • TABLE 26 OTHER SERVICES: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION)

8 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 IN VITRO DIAGNOSTIC DEVICE APPLICATIONS
    • TABLE 27 IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • 8.2.1 INFECTIOUS DISEASES
      • 8.2.1.1 Increasing incidence of infectious diseases to drive adoption of IVD devices
    • TABLE 28 INFECTIOUS DISEASES: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 8.2.2 DIABETES
      • 8.2.2.1 Rising prevalence of diabetes to drive adoption of glucose monitoring devices
    • TABLE 29 DIABETES: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 8.2.3 ONCOLOGY
      • 8.2.3.1 Rising initiatives for early detection of cancer to drive growth
    • TABLE 30 ONCOLOGY: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 8.2.4 CARDIOLOGY
      • 8.2.4.1 Increasing use of immunoassays in detection of CVD to drive growth
    • TABLE 31 CARDIOLOGY: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 8.2.5 OTHER APPLICATIONS (IVD DEVICES)
    • TABLE 32 OTHER APPLICATIONS: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 8.3 DIAGNOSTIC IMAGING DEVICE APPLICATIONS
    • TABLE 33 DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • 8.3.1 CARDIOLOGY
      • 8.3.1.1 High prevalence of CVD to drive growth
    • TABLE 34 CARDIOLOGY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 8.3.2 ONCOLOGY
      • 8.3.2.1 Wide adoption of nuclear imaging systems to distinguish between benign and malignant tumors to drive growth
    • TABLE 35 ONCOLOGY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 8.3.3 ORTHOPEDICS
      • 8.3.3.1 Effective diagnosis and prognosis of musculoskeletal disorders by imaging devices to drive growth
    • TABLE 36 ORTHOPEDICS: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 8.3.4 NEUROLOGY
      • 8.3.4.1 Innovations in 3D MRI technology to drive growth
    • TABLE 37 NEUROLOGY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 8.3.5 OTHER APPLICATIONS (DIAGNOSTIC IMAGING DEVICES)
    • TABLE 38 OTHER APPLICATIONS: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 8.4 OTHER DEVICE APPLICATIONS
    • TABLE 39 OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • 8.4.1 GASTROENTEROLOGY
      • 8.4.1.1 Surging demand for early diagnosis to propel growth
    • TABLE 40 ESTIMATED NEW GI CANCER CASES AND DEATHS IN US, 2021
    • TABLE 41 GASTROENTEROLOGY: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 8.4.2 GYNECOLOGY
      • 8.4.2.1 Rising cases of cancer among women to drive growth
    • TABLE 42 GYNECOLOGY: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION)
    • 8.4.3 OTHER APPLICATIONS (OTHER DEVICES)
    • TABLE 43 OTHER APPLICATIONS: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION)

9 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION

  • 9.1 INTRODUCTION
    • TABLE 44 DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY REGION, 2021-2028 (USD MILLION)
  • 9.2 ASIA PACIFIC
    • 9.2.1 ASIA PACIFIC: IMPACT OF ECONOMIC RECESSION
    • FIGURE 22 ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET SNAPSHOT
    • TABLE 45 ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 46 ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 47 ASIA PACIFIC: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 48 ASIA PACIFIC: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 49 ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 50 ASIA PACIFIC: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 51 ASIA PACIFIC: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 52 ASIA PACIFIC: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • 9.2.2 CHINA
      • 9.2.2.1 Low labor costs and rapidly changing healthcare infrastructure to drive growth
    • TABLE 53 CHINA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 54 CHINA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 55 CHINA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 56 CHINA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 57 CHINA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 58 CHINA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 59 CHINA: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • 9.2.3 JAPAN
      • 9.2.3.1 Need for advanced medical diagnostic tools to fuel growth
    • TABLE 60 JAPAN: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 61 JAPAN: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 62 JAPAN: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 63 JAPAN: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 64 JAPAN: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 65 JAPAN: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 66 JAPAN: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • 9.2.4 INDIA
      • 9.2.4.1 Rising contract manufacturing capabilities to support growth
    • TABLE 67 INDIA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 68 INDIA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 69 INDIA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 70 INDIA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 71 INDIA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 72 INDIA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 73 INDIA: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • 9.2.5 REST OF ASIA PACIFIC
    • TABLE 74 REST OF ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 75 REST OF ASIA PACIFIC: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 76 REST OF ASIA PACIFIC: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 77 REST OF ASIA PACIFIC: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 78 REST OF ASIA PACIFIC: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 79 REST OF ASIA PACIFIC: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 80 REST OF ASIA PACIFIC: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 9.3 NORTH AMERICA
    • 9.3.1 NORTH AMERICA: IMPACT OF ECONOMIC RECESSION
    • FIGURE 23 NORTH AMERICA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET SNAPSHOT
    • TABLE 81 NORTH AMERICA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 82 NORTH AMERICA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 83 NORTH AMERICA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 84 NORTH AMERICA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 85 NORTH AMERICA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 86 NORTH AMERICA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 87 NORTH AMERICA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 88 NORTH AMERICA: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • 9.3.2 US
      • 9.3.2.1 Rising in-house manufacturing costs to drive shift toward contract manufacturing
    • TABLE 89 US: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 90 US: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 91 US: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 92 US: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 93 US: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 94 US: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 95 US: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • 9.3.3 CANADA
      • 9.3.3.1 Strong presence of key manufacturing companies to augment market
    • TABLE 96 CANADA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 97 CANADA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 98 CANADA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 99 CANADA: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 100 CANADA: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 101 CANADA: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 102 CANADA: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 9.4 EUROPE
    • 9.4.1 EUROPE: IMPACT OF ECONOMIC RECESSION
    • TABLE 103 EUROPE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
    • TABLE 104 EUROPE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 105 EUROPE: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 106 EUROPE: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 107 EUROPE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 108 EUROPE: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 109 EUROPE: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 110 EUROPE: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • 9.4.2 GERMANY
      • 9.4.2.1 Germany to hold largest market share in Europe
    • TABLE 111 GERMANY: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 112 GERMANY: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 113 GERMANY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 114 GERMANY: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 115 GERMANY: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 116 GERMANY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 117 GERMANY: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • 9.4.3 FRANCE
      • 9.4.3.1 Strong focus on research and innovation of diagnostic devices to drive growth
    • TABLE 118 FRANCE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 119 FRANCE: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 120 FRANCE: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 121 FRANCE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 122 FRANCE: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 123 FRANCE: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 124 FRANCE: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • 9.4.4 UK
      • 9.4.4.1 Increasing accessibility of IVD devices to drive growth
    • TABLE 125 UK: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 126 UK: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 127 UK: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 128 UK: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 129 UK: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 130 UK: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 131 UK: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • 9.4.5 ITALY
      • 9.4.5.1 Lack of supporting infrastructure to restrain growth
    • TABLE 132 ITALY: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 133 ITALY: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 134 ITALY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 135 ITALY: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 136 ITALY: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 137 ITALY: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 138 ITALY: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • 9.4.6 SPAIN
      • 9.4.6.1 Increasing demand for diagnostic equipment to boost demand for contract manufacturing
    • TABLE 139 SPAIN: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 140 SPAIN: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 141 SPAIN: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 142 SPAIN: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 143 SPAIN: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 144 SPAIN: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 145 SPAIN: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • 9.4.7 REST OF EUROPE
    • TABLE 146 REST OF EUROPE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 147 REST OF EUROPE: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 148 REST OF EUROPE: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 149 REST OF EUROPE: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 150 REST OF EUROPE: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 151 REST OF EUROPE: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 152 REST OF EUROPE: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
  • 9.5 REST OF THE WORLD
    • 9.5.1 LATIN AMERICA: IMPACT OF ECONOMIC RECESSION
    • 9.5.2 MIDDLE EAST & AFRICA: IMPACT OF ECONOMIC RECESSION
    • TABLE 153 REST OF THE WORLD: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY DEVICE TYPE, 2021-2028 (USD MILLION)
    • TABLE 154 REST OF THE WORLD: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 155 REST OF THE WORLD: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY TYPE, 2021-2028 (USD MILLION)
    • TABLE 156 REST OF THE WORLD: DIAGNOSTIC CONTRACT MANUFACTURING MARKET, BY SERVICE, 2021-2028 (USD MILLION)
    • TABLE 157 REST OF THE WORLD: IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 158 REST OF THE WORLD: DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
    • TABLE 159 REST OF THE WORLD: OTHER DEVICES CONTRACT MANUFACTURING MARKET, BY APPLICATION, 2021-2028 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 OVERVIEW
  • 10.2 STRATEGIES OF KEY PLAYERS/RIGHT TO WIN
    • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY DIAGNOSTIC CONTRACT MANUFACTURERS
  • 10.3 REVENUE ANALYSIS
    • FIGURE 24 REVENUE ANALYSIS OF KEY PLAYERS
  • 10.4 MARKET SHARE ANALYSIS
    • FIGURE 25 IN VITRO DIAGNOSTIC DEVICES CONTRACT MANUFACTURING MARKET: DEGREE OF COMPETITION
    • FIGURE 26 DIAGNOSTIC IMAGING DEVICES CONTRACT MANUFACTURING MARKET: DEGREE OF COMPETITION
  • 10.5 COMPANY EVALUATION MATRIX
    • 10.5.1 STARS
    • 10.5.2 EMERGING LEADERS
    • 10.5.3 PERVASIVE PLAYERS
    • 10.5.4 PARTICIPANTS
    • FIGURE 27 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: COMPANY EVALUATION MATRIX (2022)
  • 10.6 FOOTPRINT ANALYSIS OF COMPANIES
    • TABLE 160 OVERALL FOOTPRINT OF COMPANIES
    • TABLE 161 DEVICE TYPE FOOTPRINT OF COMPANIES
    • TABLE 162 REGIONAL FOOTPRINT OF COMPANIES
  • 10.7 COMPETITIVE BENCHMARKING
    • TABLE 163 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: LIST OF KEY START-UP/SME PLAYERS
  • 10.8 COMPETITIVE SCENARIO
    • 10.8.1 PRODUCT/SERVICE LAUNCHES AND APPROVALS
    • TABLE 164 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: PRODUCT/SERVICE LAUNCHES AND APPROVALS, 2020-2023
    • 10.8.2 DEALS
    • TABLE 165 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: DEALS, 2020-2023
    • 10.8.3 OTHER DEVELOPMENTS
    • TABLE 166 DIAGNOSTIC CONTRACT MANUFACTURING MARKET: OTHER DEVELOPMENTS, 2020-2023

11 COMPANY PROFILES

  • (Business overview, Products/Services/Solutions offered, Recent Developments, MNM view)**
  • 11.1 KEY PLAYERS
    • 11.1.1 JABIL INC.
    • TABLE 167 JABIL INC.: COMPANY OVERVIEW
    • FIGURE 28 JABIL INC.: COMPANY SNAPSHOT (2022)
    • 11.1.2 FLEX LTD.
    • TABLE 168 FLEX LTD.: COMPANY OVERVIEW
    • FIGURE 29 FLEX LTD.: COMPANY SNAPSHOT (2022)
    • 11.1.3 PLEXUS CORP.
    • TABLE 169 PLEXUS CORP.: COMPANY OVERVIEW
    • FIGURE 30 PLEXUS CORP.: COMPANY SNAPSHOT (2022)
    • 11.1.4 SANMINA CORPORATION
    • TABLE 170 SANMINA CORPORATION: COMPANY OVERVIEW
    • FIGURE 31 SANMINA CORPORATION: COMPANY SNAPSHOT (2022)
    • 11.1.5 TE CONNECTIVITY LTD.
    • TABLE 171 TE CONNECTIVITY LTD.: COMPANY OVERVIEW
    • FIGURE 32 TE CONNECTIVITY LTD.: COMPANY SNAPSHOT (2022)
    • 11.1.6 CELESTICA INC.
    • TABLE 172 CELESTICA INC.: COMPANY OVERVIEW
    • FIGURE 33 CELESTICA INC.: COMPANY SNAPSHOT (2022)
    • 11.1.7 INTEGER HOLDINGS CORPORATION
    • TABLE 173 INTEGER HOLDINGS CORPORATION: COMPANY OVERVIEW
    • FIGURE 34 INTEGER HOLDINGS CORPORATION: COMPANY SNAPSHOT (2022)
    • 11.1.8 NIPRO CORPORATION
    • TABLE 174 NIPRO CORPORATION: COMPANY OVERVIEW
    • FIGURE 35 NIPRO CORPORATION: COMPANY SNAPSHOT (2022)
    • 11.1.9 THERMO FISHER SCIENTIFIC
    • TABLE 175 THERMO FISHER SCIENTIFIC: COMPANY OVERVIEW
    • FIGURE 36 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2022)
    • 11.1.10 WEST PHARMACEUTICAL SERVICES, INC.
    • TABLE 176 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY OVERVIEW
    • FIGURE 37 WEST PHARMACEUTICAL SERVICES, INC.: COMPANY SNAPSHOT (2022)
    • 11.1.11 BENCHMARK ELECTRONICS INC.
    • TABLE 177 BENCHMARK ELECTRONICS INC.: COMPANY OVERVIEW
    • FIGURE 38 BENCHMARK ELECTRONICS INC.: COMPANY SNAPSHOT (2022)
    • 11.1.12 KIMBALL ELECTRONICS INC.
    • TABLE 178 KIMBALL ELECTRONICS INC.: COMPANY OVERVIEW
    • FIGURE 39 KIMBALL ELECTRONICS INC.: COMPANY SNAPSHOT (2022)
    • 11.1.13 KMC SYSTEMS
    • TABLE 179 KMC SYSTEMS: COMPANY OVERVIEW
    • 11.1.14 SAVYON DIAGNOSTICS
    • TABLE 180 SAVYON DIAGNOSTICS: COMPANY OVERVIEW
    • 11.1.15 NOVA BIOMEDICAL
    • TABLE 181 NOVA BIOMEDICAL: COMPANY OVERVIEW
  • 11.2 OTHER PLAYERS
    • 11.2.1 CENOGENICS CORPORATION
    • 11.2.2 CONE BIOPRODUCTS
    • 11.2.3 AVIOQ, INC.
    • 11.2.4 PHILLIPS-MEDISIZE CORPORATION
    • 11.2.5 INVETECH
    • 11.2.6 MERIDIAN BIOSCIENCE, INC.
    • 11.2.7 NOLATO AB
    • 11.2.8 FUJIREBIO
    • 11.2.9 SEKISUI
    • 11.2.10 PRESTIGE DIAGNOSTICS
    • 11.2.11 BIOKIT
  • *Details on Business overview, Products/Services/Solutions offered, Recent Developments, MNM view might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS